MARKET

MRNA

MRNA

Moderna
NASDAQ
108.85
+0.96
+0.89%
Pre Market: 109.45 +0.6 +0.55% 05:43 04/25 EDT
OPEN
111.05
PREV CLOSE
107.89
HIGH
111.29
LOW
106.64
VOLUME
306
TURNOVER
0
52 WEEK HIGH
142.79
52 WEEK LOW
62.55
MARKET CAP
41.68B
P/E (TTM)
-8.8207
1D
5D
1M
3M
1Y
5Y
Moderna Stock Jumps On Collaboration With OpenAI: What's Going On?
Moderna Inc announced an ongoing collaboration with OpenAI. The company and Microsoft Corp.-backed OpenAI share a vision of AI’s transformative potential in the future of business and healthcare. Moderna says it has reached more than 80% internal adoption of OpenAI's ChatGPT.
Benzinga · 20h ago
Moderna and OpenAI in pact to fast-track drug development
Healthcare Tech Moderna and OpenAI in pact to fast-track drug development. About 3,000 employees at Massachusetts-based biotech Moderna will have access to AI firm's ChatGPT Enterprise. Moderna has partnered with AI firm OpenAI to deploy the technology across its business.
Seeking Alpha · 21h ago
MODERNA AND OPENAI COLLABORATE TO ADVANCE MRNA MEDICINE
Reuters · 21h ago
At Moderna, OpenAI's GPTs Are Changing Almost Everything
Biotechnology company Moderna is expected to announce a partnership with artificial-intelligence heavyweight OpenAI. The deal aims to use AI to automate nearly every business process at the biotechnology company. Some 3,000 Moderna employees will have access to OpenAI's ChatGPT Enterprise as part of the deal. Moderna's only commercial product is a vaccine.
The Wall Street Journal · 23h ago
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
Moderna Inc. Is set to clash with Pfizer Inc. And BioNTech SE in a pivotal London patent trial concerning the development of COVID-19 vaccines. Moderna alleges patent infringement by its competitors in utilizing the mRNA platform crucial to vaccine development. The trial is slated to take place in London.
Benzinga · 1d ago
Moderna Investors Should Beware Patent-Dispute Fallout
Moderna is facing a patent dispute over its use of lipid nanoparticles technology without proper licensing or compensation. The company's cancer vaccine showed promising results in a clinical trial. Moderna's stock rose after positive results from its cancer vaccine trial. I believe the company's defense, citing an obscure law, is unlikely to hold up in court. The outcome could result in significant damages.
Seeking Alpha · 1d ago
S&P 500 stocks with biggest estimated EPS declines for Q1
Seeking Alpha · 1d ago
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Pfizer vs Moderna battle over COVID vaccine patents begins in UK. Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19. Moderna says Pfizer copied its technology before the pandemic began.
Reuters · 1d ago
More
About MRNA
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.